The FamiCord Group strengthens its position in Turkey

FamiCord Group has concluded an investment agreement regarding the purchase of shares in the Turkish stem cell bank which has operated so far within the structure of the Acıbadem Healthcare Group.

FamiCord group has now 70% of shares in the newly created Famicord – Acibadem company. The company was formed from a separate part of the enterprise with the Acıbadem Healthcare Group, to which the scope of activities including processing, testing and storage of cord blood was transferred. The remaining 30% of shares will be owned by the Acıbadem Healthcare Group. The purchase is financed from the resources acquired within a private subscription of PBKM shares which took place last year.

Recently added

03 June 2025 FamiCord Group’s Dubai Laboratory Earns Prestigious AABB Accreditation Dubai, UAE – [3.06.2025] – FamiCord Group, the largest cord blood bank in Europe, proudly announces that its state-of-the-art laboratory in Dubai has received the prestigious accreditation from the Association for the Advancement of Blood & Biotherapies (AABB) – a globally recognized standard of excellence in the field of cellular and blood banking services. Read more
06 September 2024 Dr Tomasz Baran – FamiCord Vicepresident – speaks on cord blood banking at world’s largest cord blood conference Tomasz Baran, MD, MBA, Vice President of FamiCord Group, recently shared his expertise on cord blood banking at the world’s largest cord blood conference... Read more